Libya, Egypt Sign Healthcare Cooperation Pact
The memorandum of understanding covers disease prevention, pharmaceutical production, and medical training between the two countries.
Updated on Nov. 7, 2026 in Healthcare
Libya and Egypt signed a memorandum of understanding on healthcare cooperation in Tripoli on Saturday, November 7, 2026. Libya's Health Minister Mohamed Al-Ghouj and Egyptian Foreign Minister Badr Abdelatty signed the agreement on the sidelines of the 22nd session of the CEN-SAD Executive Council.
Why it matters
The agreement establishes a framework for sharing expertise across a broad range of health areas, from infectious and non-communicable disease efforts to laboratory services and blood banks. It formalizes bilateral health ties between two neighboring North African states.
The agreement was signed at the 22nd session of the CEN-SAD Executive Council, a regional body, on November 7, 2026. The extraction does not specify funding amounts, budgets, or implementation timelines for the cooperation.
The players
Mohamed Al-Ghouj
Libya's Health Minister, who signed the agreement on behalf of the Libyan government.
Badr Abdelatty
Egypt's Foreign Minister, who signed the agreement on behalf of the Egyptian government.
The details
The memorandum covers disease surveillance, pharmaceutical manufacturing, clinical pharmacy, medicine safety monitoring, laboratory services, and blood banks. It also addresses medical and pharmaceutical training, antimicrobial resistance research, infection prevention and control, health insurance, and primary healthcare programmes.
Timeline
Saturday, November 7, 2026: Libya and Egypt sign the healthcare memorandum of understanding in Tripoli.
Regional Context
The signing took place on the sidelines of the 22nd session of the CEN-SAD Executive Council, placing the bilateral pact within that regional body's ongoing agenda. The extraction does not identify further precedent agreements or historical parallels.
For readers in North Africa and beyond, the agreement may shape the availability of medicines, medical training opportunities, and disease prevention programs in Libya and Egypt. The extraction does not specify when or how these effects will reach patients or providers.
The takeaway
Cross-border health cooperation can pair disease surveillance with pharmaceutical manufacturing and workforce training, a combination that may benefit both signatories' health systems over time. Readers tracking regional health policy should watch for implementation details that follow the memorandum.
Further reading
For related coverage of health policy and industry developments, see Healthcare.
